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EVALUATION OF BLOOD ASSAYS FOR DETECTION OF
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ABSTRACT: Surveillance and control activities related to bovine tuberculosis (TB) in free-ranging,
Michigan white-tailed deer (Odocoileus virginianus) have been underway for over a decade, with
significant progress. However, foci of higher TB prevalence on private lands and limited agency
ability to eliminate them using broad control strategies have led to development and trial of new
control strategies, such as live trapping, testing, and culling or release. Such strategies require a
prompt, accurate live animal test, which has thus far been lacking. We report here the ability of seven
candidate blood assays to determine the TB infection status of Michigan deer. Our aims were
twofold: to characterize the accuracy of the tests using field-collected samples and to evaluate the
feasibility of the tests for use in a test-and-cull strategy. Samples were collected from 760 deer
obtained via five different surveys conducted between 2004 and 2007. Blood samples were subjected
to one or more of the candidate blood assays and evaluated against the results of mycobacterial
culture of the cranial lymph nodes. Sensitivities of the tests ranged from 46% to 68%, whereas
specificities and negative predictive values were all .92%. Positive predictive values were highly
variable. An exploratory analysis of associations among several host and sampling-related factors and
the agreement between blood assay and culture results suggested these assays were minimally
affected. This study demonstrated the capabilities and limitations of several available blood tests for
Mycobacterium bovis on specimens obtained through a variety of field surveillance methods.
Although these blood assays cannot replace mass culling, information on their performance may
prove useful as wildlife disease managers develop innovative methods of detecting infected animals
where mass culling is publicly unacceptable and cannot be used as a control strategy.
Key words: Bovine tuberculosis, diagnostic tests, Mycobacterium bovis, Odocoileus
virginianus, white-tailed deer.
INTRODUCTION
Surveillance and control activities for
bovine tuberculosis (TB; caused by Myco-
bacterium bovis) in free-ranging, Michigan
white-tailed deer (Odocoileus virginianus;
Schmitt et al., 1997) have now been
underway for more than a decade (O’Brien
et al., 2006). Significant progress has been
made lowering the prevalence of TB in
deer in the most affected area by approx-
imately 70%. The primary factors likely
responsible for this progress have been
twofold: reduction of deer densities
through hunting and restrictions on sup-
plemental feeding and baiting of deer by
the public. These broad strategies, of the
Michigan Department of Natural Resourc-
es (MDNR), implemented with the coop-
eration of Michigan deer hunters, have
resulted in a halving of the deer population
in the five-county TB area (Rudolph, 2006)
and a substantial reduction in supplemental
feeding (Matthews and Carlson, 2005).
However, as hunters see fewer deer, their
willingness to sustain aggressive harvests
has waned (Van Deelen and Etter, 2003),
and in general, public resentment of
control measures for TB in wildlife has
grown (O’Brien et al., 2006).
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Although prevalence has been greatly
reduced over the TB area as a whole,
clusters of higher prevalence have long
been known to exist on privately owned
land and those rates persist. Epidemiolog-
ically, geographic area (O’Brien et al.,
2002) and land ownership (Hickling, 2002)
are the strongest predictors of TB occur-
rence. The current broad MDNR control
strategies have limited ability to eliminate
such clusters because private landowners
can limit hunter access to their lands,
effectively controlling harvest pressure
and the size of the local deer population.
Although large-scale agency culling of
deer is theoretically an option, very little
public or political support exists (Dorn
and Mertig, 2005), Consequently, such
culling is not a viable management option.
Collectively, these factors can effectively
preclude eradication of TB from the deer
and from Michigan unless new, more
publicly acceptable control strategies can
be devised (O’Brien et al., 2006).
Beginning in January 2004, a new,
cooperative, TB control strategy was
instituted by MDNR with private land-
owners in the core area and with the US
Department of Agriculture’s Animal and
Plant Health Inspection Service-Wildlife
Services (APHIS-WS) branch (Schmitt et
al., 2004). The program involved live
trapping of deer in high-prevalence areas,
testing them with a commercially available
gamma-interferon blood test and culling
of test-positive deer. Although logistically
workable and well-supported by landown-
ers and policymakers, performance of the
gamma-interferon assay was a critical
limitation (Schmitt et al., 2004). Others
have also shown that assay to have limited
usefulness with samples from white-tailed
deer (Waters et al., 2007). Problems are
not uncommon when using serologic tests
to diagnose M. bovis in wildlife reservoirs
(Cousins and Florisson, 2005). A TB test
method with improved accuracy was
clearly necessary for the test-and-cull
program to be viable and cost effective
as a disease-control strategy.
We report here on the ability of seven
candidate blood assays (Waters et al.,
2004) to determine the TB infection status
of Michigan white-tailed deer. Our aims
were twofold: to characterize the accuracy
of the tests using field-collected samples
and to evaluate the feasibility of perform-
ing the tests as part of the test-and-cull
strategy.
MATERIALS AND METHODS
Study area and population
The study population inhabited parts of
Deer Management Unit 452 (44u409–45u009N,
83u309–84u059W), considered to be the core of
the TB outbreak area (O’Brien et al., 2002), in
northeastern Lower Michigan. Deer samples
were obtained from five sources: 1) hunter
harvests in 2004 and 2005; 2) small-scale culls
conducted by a hunt club in January 2006 and
February 2007 as part of a herd-health
program; 3) carcasses bearing gross lesions
consistent with disseminated TB presented to
the MDNR Wildlife Disease Laboratory
(WDL) from 2005 to 2007; 4) nuisance deer
shot on farms by APHIS-WS staff under
MDNR-issued disease-control permits; and
5) depopulation of a captive cervid shooting
facility confirmed to be positive for M. bovis in
December 2006. All deer other than those
from the captive cervid shooting facility were
free ranging.
To obtain biologic samples from hunter-
harvested deer, MDNR sought the coopera-
tion of private land owners and hunt club
managers in areas encompassing clusters of
high TB prevalence (O’Brien et al., 2006) to
maximize the likelihood of obtaining M. bovis-
positive samples. Sampling kits, consisting of a
uniquely numbered jaw tag, 2–10 cc Vacutai-
ner (Becton-Dickinson, Cockeysville, Mary-
land, USA) blood collection tubes (one with
serum separator, one with sodium edetic acid
as an anticoagulant) prenumbered to match
the tag, and instructions on how to collect
blood from the chest cavity and tag the deer’s
head, were provided to club managers. They
distributed the kits to members licensed to
hunt deer during regular autumn hunting
seasons.
At harvest, deer heads were disarticulated
and tagged to document location (township,
range, and section), date, and contact infor-
mation for the hunter. Heads and blood
samples from the same deer were bagged,
sealed, and shipped to WDL. The sex (based
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on presence or absence of antlers) and age
(estimated by tooth eruption and wear;
Severinghaus, 1949) of the deer were record-
ed. All data were archived (Microsoft Access
2002, Microsoft Corporation, Redmond, Wash-
ington, USA).
Blood samples were obtained from the chest
cavity with a disposable pipette, immediately
after the deer were shot (culled, depopulated,
and nuisance deer) and at the time grossly
lesioned carcasses were examined at WDL.
Previous work (O’Brien et al., 2001) had
shown deer with gross lesions were likely to
yield positive cultures for M. bovis. Serum-
separator tubes were centrifuged (Adams
Compact II centrifuge, Becton-Dickinson)
for 10 min at 1,163 3 G, and the serum was
decanted into 5-ml low-temperature freezer
vials (VWR International, Inc., West Chester,
Pennsylvania, USA). The subjective degree of
hemolysis for all serum samples was assessed
visually by a single technician.
The submandibular, parotid, and medial
retropharyngeal lymph nodes and the palatine
tonsils from hunter-harvested, culled, depop-
ulated, and nuisance deer were dissected
bilaterally and pooled for each deer in a
sterile, 50-ml polypropylene, screw-top centri-
fuge tube (Corning Incorporated, Corning,
New York, USA) for bacterial culture, as
previously described (O’Brien et al., 2004).
Tissue samples that were similarly collected
from deer with gross lesions typically included
parietal pleura, medial retropharyngeal lymph
nodes, and/or lung.
Bacteriologic analyses
Tissue samples were tested at the Michigan
Department of Community Health (MDCH)
Tuberculosis Laboratory by methods de-
scribed previously (O’Brien et al., 2004). Two
smears were prepared from processed speci-
men sediments. One was heat-fixed, stained
with fluorescent Auramine-O (Kent and Ku-
bica, 1985) and examined microscopically for
acid-fast bacteria. When positive or suspicious,
the second smear was stained via Ziehl-
Neelsen for confirmation. The remaining
sediment was resuspended and inoculated to
a Lowenstein Jensen medium slant (Becton-
Dickinson), a Middlebrook 7H11S medium
slant (Becton-Dickinson), and a Bactec 12B
broth vial (Becton-Dickinson). Media were
examined at least weekly for 8 wk for bacterial
growth. Acid-fast growth, as determined by a
Ziehl-Neelsen-stained smear, was tested by
genetic probe (Accuprobe, Gen-Probe, San
Diego, California, USA) to differentiate mem-
bers of the Mycobacterium tuberculosis com-
plex (Risner et al., 1994). Biochemical testing
and high-performance liquid chromatography
distinguished M. bovis (Butler et al., 1991,
Metchock et al., 1995).
Immunologic analyses
Workers performing all blood tests were
blinded to the pathology and mycobacterial
culture status of all samples.
Rapid test: A lateral-flow assay (CervidTB
STAT-PAKH) was developed by Chembio
Diagnostic Systems, Inc. (Medford, New York,
USA) to detect antibodies in various host
species (Lyashchenko et al., 2006). The test
employs a unique cocktail of M. bovis antigens
and blue, latex, bead-based signal-detection
system. Thirty microliters of serum or whole
blood and three drops of sample diluent were
added sequentially to the sample pad. Results
were read at 20 min. Any visible band in the
test area was considered a positive result.
Multiantigen print immunoassay (MAPIATM): Eight
recombinant proteins of M. bovis were used
(Rv numbers per Cole et al. [1998] in
brackets): ESAT-6 [Rv3875] and CFP-10
[Rv3874] (Statens Serum Institut, Copenha-
gen, Denmark); MPB59 [Rv1886c], MPB64
[Rv1980c], MPB70 [Rv2875], and MPB83
[Rv2873] (Veterinary Sciences Division, Stor-
mont, Belfast, UK); Acr1 [Rv3391] and PstS1
[Rv0934] (Standard Diagnostics, Seoul, South
Korea). Two polyprotein fusions (CFP-10/
ESAT-6 and Acr1/MPB83; Statens Serum
Institut, Copenhagen, Denmark) and one
native antigen (M. bovis culture filtrate T/91/
1378; Veterinary Sciences Division, Stormont,
Belfast, UK) were also employed.
The multiantigen print immunoassay was
performed as described previously (Lyash-
chenko et al., 2000). Antigens were immobi-
lized on nitrocellulose (Schleicher & Schuell,
Keene, New Hampshire, USA) using a semi-
automated airbrush-printing device (Linomat
IV, Camag Scientific Inc., Wilmington, Dela-
ware, USA). The membrane was cut into 4-
mm-wide strips, blocked for 1 hr with 1%
nonfat skim milk in phosphate-buffered saline
with 0.05% Tween 20 (PBST; Sigma-Aldrich,
St. Louis, Missouri, USA), and incubated for
1 hr with serum samples diluted to 1:40. After
washing, strips were incubated overnight with
peroxidase-conjugated Protein G (Sigma-Al-
drich) diluted to 1:1,000. Deer immunoglob-
ulin G (IgG) antibodies, bound to printed
antigens, were visualized with 3,39,5,59-tetra-
methyl benzidine (Kirkegaard and Perry Lab-
oratories, Inc., Gaithersburg, Maryland, USA).
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Immunoblot assay: Electrophoresis and immu-
noblot assays were performed using described
procedures (Bannantine and Stabel, 2000)
with the following modifications. Antigens for
immunoblot were either a whole-cell sonicate
of M. bovis strain 95-1315 or recombinant
MPB83. The sonicate was prepared as de-
scribed (Waters et al., 2005). Antigen was
electrophoresed through preparative 10% (w/
v) polyacrylamide gels and transferred to
nitrocellulose. These membranes were placed
in blocking solution consisting of PBST and
2% (w/v) bovine serum albumin (PBST-BSA),
then into the slot-blotting device (Bio-Rad
Laboratories, Richmond, California, USA)
with individual sera, diluted to 1:200 in
PBST-BSA, added to independent slots. After
2 hr incubation with gentle rocking, blots were
washed five times with PBST and incubated
with horseradish peroxidase-conjugated rabbit
anti-deer (Kirkegaard and Perry) diluted to
1:20,000 in PBST-BSA for 1.5 hr. Blots were
again washed four times with PBST and were
developed for chemiluminescence in Super-
Signal detection reagent (Pierce Chemical
Company, Rockford, Illinois, USA).
Enzyme-linked immunosorbent assay (ELISA): Li-
poarabinomannan-enriched antigen was pre-
pared from M. bovis strain 95-1315 as
described (Waters et al., 2002). Immulon II
96-well microtiter plates (Dynatech; Chantilly,
Virginia, USA) were coated with 100 ml/well
(4 mg) antigen diluted in carbonate/bicarbon-
ate-coating buffer (pH 9.6). Antigen-coated
plates, including control wells, were incubated
for 15 hr at 4 C, washed three times with
200 ml/well PBST, and blocked with 200 ml/
well of milk diluent/blocking solution (Kirke-
gaard and Perry). After incubation for 1 hr at
37 C, wells were washed nine times with
200 ml/well PBST, and test sera added (100 ml/
well) in duplicate. Test and control sera were
diluted 1:100 in PBS containing 0.1% gelatin.
After incubation for 20 hr at 4 C, wells were
washed nine times with 200 ml/well PBST and
incubated 1 hr at 37 C with 100 ml/well of
horseradish peroxidase-conjugated anti-cer-
vine IgG heavy and light chains (Kirkegaard
and Perry) diluted 1:1,000 in PBS plus 0.1%
gelatin. Wells were again washed nine times
with PBST and incubated 4 min at 20 C with
100 ml/well of SureBlueTM TMB peroxidase
substrate (Kirkegaard and Perry). The reaction
was stopped by addition of 100 ml/well of
0.18M sulfuric acid, and the absorbance
(450 nm) of individual wells was measured
using an automated ELISA plate reader
(Molecular Devices, Menlo Park, California,
USA). Data were evaluated as changes in
optical density readings (i.e., DOD) calculated
by subtracting the mean optical density
readings for wells receiving coating buffer
alone (two replicates) from the mean optical
density readings for antigen-coated wells (two
replicates) receiving the same serum sample.
Two cut-off values, DOD$0.25 and DOD$
0.3, were evaluated separately as decision rules
to determine whether a given sample was
considered positive for M. bovis.
Statistical analyses
Seven blood assays were evaluated: rapid test
on whole blood; rapid test on serum; multi-
antigen print immunoassay on serum; immu-
noblot for M. bovis whole-cell sonicate on
serum; immunoblot for MPB83 on serum; and
ELISA with cut-off points of DOD$0.25 and
DOD$0.3 on serum. The result of each test
was binary, either TB positive or TB negative.
All assays were evaluated against the gold
standard of mycobacterial culture by calculat-
ing sensitivity, specificity, and the predictive
values of positive and negative tests (Thrusfield,
1995) using freely available software (Lowry,
2007), with 95% percent confidence limits
calculated by the continuity-corrected effi-
cient-score method (Newcombe, 1998).
Misclassification of true disease status may
occur when factors affect the performance of
diagnostic tests (Thrusfield, 1995). Consequent-
ly, exploratory analyses were carried out to
assess the influence of two host factors (sex and
age) and three sampling-related factors (source
of sample, days elapsed between sampling and
processing, and for tests on serum, degree of
hemolysis) on the agreement between the blood
assays and culture. Days elapsed, or lag days,
was the number of days between the date the
deer was killed and the date the rapid test on
whole blood was run and the blood was spun
down to separate serum. Factors were coded as
follows: 1) sex (binary, reference level: female);
2) age (ordinal, by quartiles, reference level:
#1.5 yr); 3) source of sample (nominal, five
levels, reference level: hunter harvested); 4) lag
days (ordinal, three levels, reference level: 0
days); 5) hemolysis (ordinal, five levels, refer-
ence level: clear). For each assay on each deer, a
binary variable named agreement took the value
yes, if blood test and culture results agreed, and
no otherwise. A two-tailed Fisher’s exact test
(Proc Freq, SAS version 9, Cary, North
Carolina, USA) assessed whether significant
variation in agreement (considered attained at
P#0.1) occurred across levels of each host and
sampling factor. Those found significant for a
given assay were retained for multivariable
modeling.
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Retained factors were used as predictors in a
series of multivariable logistic regression mod-
els (Kleinbaum et al., 1998) for each blood assay
with agreement as the response, modeling the
probability that agreement5yes. Candidate
models were ranked, and the best-approximat-
ing models chosen by methods previously
described (Burnham and Anderson, 1998),
using Akaike’s Information Criterion corrected
for small sample bias (AICc; Lebreton et al.,
1992), the AICc difference (Di) between each
candidate model and the best approximating
model, and normalized Akaike weights (wi).
Candidate models where Di#2 were consid-
ered to have substantial support from the data,
and those where 2,Di#4 were considered
reasonably plausible. Both groups were consid-
ered competing. Models where Di.4 were
considered a poor fit to the data. Associations
between test agreement and the host/sampling
factors in best-approximating models were
assessed via odds ratios (Kleinbaum et al.,
1998). Where more than one model was
competing for best-approximating model, mod-
el averaging of parameter estimates was used to
determine odds ratios. Associations were con-
sidered significant at P#0.05.
RESULTS
Blood and tissue samples from 760 deer
were obtained, and tissues were cultured
for M. bovis. The volume and quality of
blood samples was highly variable, partic-
ularly among hunter-harvested deer. In
some cases, whole blood or serum was not
submitted, or volumes were insufficient
for all seven assays. The immunoblot on
whole-cell sonicate and the two ELISA
assays were not performed after February
2006. The sensitivity of the immunoblot
was insufficient to justify its expense,
whereas the ELISAs were discontinued
following departure of the staff who had
conducted them. Consequently, not all
assays were run on all deer. Nevertheless,
blood samples from culture-positive deer
were distributed relatively evenly among
the assay methods (Table 1). There was no
significant variation in the proportion of
samples from culture-positive deer that
were tested by each blood assay (x253.45,
df56, P50.75). Results for the immuno-
blot on whole-cell sonicate and the
ELISAs were obtained for 45% of the T
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deer, whereas the rapid test on whole
blood and the immunoblot on MPB83
antigen were performed on 72% and 90%,
respectively. More than 97% of the
samples were tested by both the rapid
test on serum and the multiantigen print
immunoassay (Table 2).
Point estimates of the sensitivity of the
blood assays ranged from 46% to 68%,
whereas specificities and negative predic-
tive values were all .92% (Table 1).
Positive predictive values were highly
variable, ranging from 19% for the immu-
noblot on whole-cell sonicate to 70% for
the rapid test on whole blood.
Best-approximating models of the influ-
ence of host and sampling factors on blood
assay vs. culture agreement were dominat-
ed by sample source and the lag days
between sample collection and processing
(Table 3). There were no significant pre-
dictors of agreement in five of 13 (39%) of
the competing models. Sample source was a
significant predictor in the other eight
models, with significant variation attribut-
able to grossly lesioned WDL carcasses.
Regardless of blood assay, results for those
samples were less likely to agree with
culture than hunter-harvested samples.
Assay results for hunter-harvested samples
were between eight and 125 times more
likely to agree with culture than samples
from lesioned carcasses. Hemolysis was a
significant predictor of agreement only in
the best-approximating model for the rapid
test on serum, where results on more
hemolyzed samples were more likely to
agree with culture (odds ratios and 95%
confidence limits compared with clear
samples: light red, 6.3 [1.4, 29]; medium
red, 14.0 [1.4, 136]; dark red, 10.6 [1.6, 72]).
DISCUSSION
The North American paradigm of pub-
lic ownership of wildlife has far-reaching,
sometimes unanticipated, implications.
Even where they are accepted by wildlife
managers as justified and scientifically
sound, disease control strategies, such as
mass depopulation, that are standard
practice for privately owned livestock
may be publicly unacceptable for use on
free-ranging wildlife (Heberlein, 2004),
and so, may not be implemented on the
scale necessary to be effective. With such
tools made politically unusable, managers
of wildlife diseases may increasingly be
forced to develop more innovative meth-
ods of discriminating infected from non-
infected animals as an antecedent to
control.
The intent of this study was to evaluate
a number of candidate blood assays
simultaneously under realistic conditions
and with specimens likely to be represen-
tative of those available from TB surveil-
lance in Michigan. Although the sensitiv-
ity, specificity, and the predictive values
for the various tests are reported collec-
tively here, direct comparisons between
tests should be approached with caution.
Because of limitations in sample volume
and test availability across years, no two
blood tests evaluated exactly the same data
set, although overlap was substantial
(Table 2). There was no significant varia-
tion in the proportion of samples from
culture-positive deer that were tested by
each blood assay (Table 1), providing little
evidence that differential testing of cul-
ture-positive animals by some assays, and
not others, biased the results.
All of the blood assays displayed high
specificities and negative predictive val-
ues. Public distaste for the killing of large
numbers of ‘‘innocent’’ (i.e., TB-negative)
deer in the pursuit of a few TB-positive
animals is the fundamental basis for
opposition to widespread culling as a
disease-management tool. These blood
tests were all quite unlikely to falsely
identify a TB-negative deer as being
positive, boding well for public accep-
tance. Granted, the public would have
difficulty knowing when false-positive
deer were culled. However, if close
scrutiny of publicly accessible disease-
control plans should reveal a lack of
agency candor with respect to the accura-
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cy of the diagnostic tests, the distrust
created could critically undermine the
credibility of wildlife managers for years.
Without that credibility, the already pre-
carious public support for disease control
could further weaken (Heberlein, 2004),
and progress toward eradication could
slow or cease.
As would be expected when specificities
are high, sensitivities and positive predic-
tive values were, in general, considerably
lower. This imposes formidable obstacles.
First, approximately one third to half of the
truly TB-positive deer tested will be
identified as TB negative. Such animals
will not be removed from the population by
a test-and-cull strategy, such as ours, and
will continue to pose an exposure risk. On
that basis alone, it is understandable that
test-and-cull programs using these blood
assays could be rejected as TB-control
strategies out of hand. Clearly, such
strategies are not yet, and may never be, a
substitute for mass culling, where depop-
ulation is a tool actually available to wildlife
managers. However, in situations like
Michigan’s where depopulation simply
cannot be used because of public opposi-
tion, assays with even modest sensitivity
would allow removal of some positive
animals that would otherwise remain in
the population. Whether test-and-cull
strategies based on such tests could remove
enough deer to have a meaningful effect on
overall transmission and maintenance of
TB remains to be determined. Second, and
more important from a practical stand-
point, false-negative deer adversely affect
the cost effectiveness of test-and-cull pro-
grams, increasing the money and effort
expended to remove a positive deer from
the population. As the prevalence of TB in
the population decreases, those costs may
increase prohibitively. Incorporating vacci-
nation of test-negative deer into a test-and-
cull strategy should improve cost effective-
ness. Early investigations of bacillus Calm-
ette-Gue´rin vaccination of white-tailed
deer are promising (Palmer et al., 2007;
Nol et al., 2008).
The blood assays in this study were
minimally affected by variations in the
host and sampling factors. All the tests
were robust to differences in sex, age, and
sample quality that are likely to occur
across the surveillance methods typically
used to collect wildlife samples. The
Office International des E´pizooties has
stipulated that estimates of diagnostic
sensitivity should be made in populations
that mimic those in which the diagnostic
tests will be used (Cousins and Florisson,
2005). Thus, quantitative information on
how host- or sampling-related factors
affect the performance of the tests is
critical, so that variations in accuracy can
be properly attributed either to those
factors or to the tests themselves. Some
of the deer anticipated to show the
strongest agreement between the blood
assays and culture (grossly lesioned car-
casses sampled at WDL), in fact, showed
the poorest agreement. Fifteen (83%) of
the 18 lesioned carcasses cultured positive
for M. bovis. In all but one instance where
the assay results disagreed with culture, a
false-negative resulted. Thus, lowered
sensitivity of the assays was the principal
cause of this disagreement. The carcasses
were often eviscerated and sometimes
quite desiccated. The red fluid sampled
from these deer and presumed to be blood
may well have been a mixture of blood,
water, rumen contents, and other fluids,
which may not have contained sufficient
antibodies to diagnose TB using the
assays. In addition, because these carcass-
es comprised only about 2% of all blood
samples tested, it is also possible that their
effect on agreement would be moderated,
or made insignificant, with a larger sample
size.
Cousins and Florisson (2005) reviewed
tests available to diagnose TB in a variety
of wildlife species and the difficulties of
test validation. They note that, in general,
detection of humoral antibody is consid-
ered a poor indicator of infection, and that
antibody-based tests, such as those we
evaluated, are likely to have limited
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application in TB-control programs. That
said, they also point out that recent
advances in availability of purified anti-
gens, technologies for antibody detection,
and the undeniable logistic advantages of
antibody tests with respect to cost and
ease of use, have sustained continued
interest in data on their diagnostic perfor-
mance. In particular, results from large
samples of naturally exposed animals in
low-TB-prevalence populations that have
been simultaneously tested via the gold
standard, mycobacterial culture, continue
to be needed (Cousins and Florisson,
2005). Our study meets all of these criteria
and has documented the performance of
several available blood assays for M. bovis
on specimens obtained through a variety
of field surveillance methods, where use of
the intradermal tuberculin test is not an
option. The majority of the tests evaluated
require a well-equipped, climate-con-
trolled laboratory and skilled laboratory
personnel to conduct. Where these needs
can be satisfied, the tests may be valuable
additions to the tools available for diagno-
sis of M. bovis in white-tailed deer. They
may be of limited utility, however, in field
operations where testing necessarily must
be performed in adverse weather by staff
unskilled in laboratory technique. In such
situations, the logistic advantages of rapid,
animal-side screening assays like the
CervidTB STAT-PAKH may prove diffi-
cult to ignore.
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